DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 107 filers reported holding DEPOMED INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $28,776,000 | -27.7% | 1,596,879 | +0.2% | 0.00% | -33.3% |
Q3 2016 | $39,780,000 | +36.0% | 1,593,101 | +6.9% | 0.01% | +20.0% |
Q2 2016 | $29,251,000 | +46.8% | 1,490,876 | +4.2% | 0.01% | +66.7% |
Q1 2016 | $19,928,000 | -22.4% | 1,430,571 | +0.9% | 0.00% | -25.0% |
Q4 2015 | $25,693,000 | -4.2% | 1,417,138 | -0.4% | 0.00% | -20.0% |
Q3 2015 | $26,817,000 | -23.8% | 1,422,666 | -13.2% | 0.01% | -16.7% |
Q2 2015 | $35,170,000 | -7.5% | 1,638,880 | -3.4% | 0.01% | 0.0% |
Q1 2015 | $38,024,000 | +38.6% | 1,696,735 | -0.3% | 0.01% | +50.0% |
Q4 2014 | $27,426,000 | +7.2% | 1,702,397 | +1.1% | 0.00% | 0.0% |
Q3 2014 | $25,583,000 | -4.9% | 1,684,214 | -13.0% | 0.00% | 0.0% |
Q2 2014 | $26,897,000 | -6.5% | 1,935,011 | -2.5% | 0.00% | -20.0% |
Q1 2014 | $28,779,000 | +46.2% | 1,984,785 | +6.6% | 0.01% | +66.7% |
Q4 2013 | $19,691,000 | +42.0% | 1,861,131 | +0.3% | 0.00% | 0.0% |
Q3 2013 | $13,865,000 | +34.3% | 1,856,025 | +1.1% | 0.00% | +50.0% |
Q2 2013 | $10,321,000 | – | 1,836,558 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |